2022 has been a big year for the world of lab-grown meat. Not only did we see it begin to show up at fine dining locations in Singapore and see hundreds of millions of venture funding poured into the sector, but this year also marked the first time the US FDA sent out a “No Questions” letter to a cultivated meat company, signaling that it believes that UPSIDE’s cultivate chicken is safe for consumers.
And while 2022 was full of momentous news for alt-meat, 2023 is guaranteed to be even more action-packed. Numerous cultivated meat companies are beginning to scale up the production of their products, big food companies are evaluating how to fit cultivated meat into their product portfolios, and innovators continue to find breakthrough ideas that will help cellular agriculture make a dent in traditional animal agriculture.
To help 2023 get kicked off, we’ll be bringing the conversation about how to scale cultivated meat and other alternative protein to the big stage of the Consumer Electronics Show at the CES Food Tech Conference this coming January. I will be taking the stage to interview some of the biggest names in the future of protein in a session called “Scaling Towards a Trillion Dollar Alternative Protein Industry,” including the CEO of UPSIDE Foods Uma Valeti, Head of Operations for Perfect Day, Shayri RoyChoudhury, and the CEO of SuperMeat, Ido Savir.
This session is just one of a full day of programming on food tech at the world’s biggest technology conference. On January 5th at the CES Food Tech Conference, we’ll also be talking about the tech-powered restaurant, how the consumer kitchen will change in the future, the future of farming, and even how we will grow food in space!
If you are an entrepreneur interested in the opportunities presented by the future of food, you won’t want to miss it. You can find out more and buy tickets to the CES Food Tech conference here.
We’ll see you in Vegas.
If you’re interested in sponsoring our CES food tech conference or the Food Tech Happy Hour, drop us a line.
Leave a Reply